Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer

被引：0
|
作者：
Hyo Jin Lee
Do Yeun Cho
Ji Chan Park
Sang Byung Bae
Kyu Taek Lee
In Sung Cho
Chang Soon Han
Suk Young Park
Hwan Jung Yun
Samyong Kim
机构：
[1] Chungnam National University Hospital,Division of Hematology/Oncology, Department of Internal Medicine
[2] Konyang University Hospital,Department of Internal Medicine
[3] Daejeon St. Mary’s Hospital,Department of Internal Medicine
[4] Soon Chun Hyang University Cheonan Hospital,Department of Internal Medicine
[5] Eulji University Hospital,Department of Internal Medicine
[6] Cheongju St. Mary’s Hospital,Department of Internal Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Gastric cancer; Paclitaxel; 5-Fluorouracil; Leucovorin; Biweekly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer
    Lee, H. J.
    Yun, H. J.
    Kim, S.
    Cho, D. Y.
    Park, J. C.
    Park, S. Y.
    Bae, S. B.
    Lee, K. T.
    Cho, I. S.
    Han, C. S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 427 - 432
  • [2] Phase II Study of Biweekly Paclitaxel Plus Infusional 5-Fluorouracil and Leucovorin as First-Line Chemotherapy in Patients With Advanced Gastric Cancer
    Wang, Fenghua
    Wang, Zhiqiang
    Zhou, Ningning
    An, Xin
    Xu, Ruihua
    He, Youjian
    Li, Yuhong
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (04): : 401 - 405
  • [3] A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer
    Chong Kun Im
    Hei-Cheul Jeung
    Sun Young Rha
    Nae Choon Yoo
    Sung Hoon Noh
    Jae Kyung Roh
    Hyun Cheol Chung
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 315 - 321
  • [4] A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer
    Im, Chong Kun
    Jeung, Hei-Cheul
    Rha, Sun Young
    Yoo, Nae Choon
    Noh, Sung Hoon
    Roh, Jae Kyung
    Chung, Hyun Cheol
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) : 315 - 321
  • [5] A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer
    Gu, Yanhong
    Shu, Yongqian
    Xu, Qiang
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (04) : 293 - 296
  • [6] Weekly infusional 5-fluorouracil and leucovorin and biweekly cisplatin, a convenient treatment option in advanced gastric cancer
    Purim, O.
    Kundel, Y.
    Figer, A.
    Stemmer, S.
    Sulkes, A.
    Brenner, B.
    ANNALS OF ONCOLOGY, 2006, 17 : 97 - 98
  • [7] Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil
    Park, Se Hoon
    Lee, Woon Kee
    Chung, Min
    Lee, Yuna
    Han, Sang Hoon
    Bang, Soo-Mee
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    ANTI-CANCER DRUGS, 2006, 17 (02) : 225 - 229
  • [8] A phase II trial of 5-fluorouracil, leucovorin and mitomycin C in patients with advanced gastric cancer
    Kim, Sung Rok
    Yuh, Young Jin
    Sohn, Byeong Seok
    Yang, Sung Hyun
    TUMORI, 2011, 97 (06) : 698 - 703
  • [9] A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer
    Au, E
    Koo, WH
    Tan, EH
    Ang, PT
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (04) : 300 - 303
  • [10] A phase II trial of 5-fluorouracil, leucovorin and mitomycin C in patients with advanced gastric cancer
    Kim, SR
    Yuh, YJ
    Kim, HJ
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 254 - 254
12345